Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baricitinib + Phototherapy in Progressive Vitiligo
NCT04822584Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Jul 2021
- Primary completion
- Apr 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of baricitinib in Vitiligo, sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Jul 2021; status: completed.
02
Drugs
baricitinib
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT04822584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04822584.